An Online Behavior Change Intervention to Promote Physical Activity in Adults With Asthma
An Online Behavior Change Intervention to Promote Physical Activity in Adults With Asthma: a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Karina Furlanetto, PhD
- Phone Number: +55 43 991144621
- Email: ka_furlanetto@hotmail.com
Study Locations
-
-
Paraná
-
Londrina, Paraná, Brazil, 86041-14
- Centro de Pesquisa e Pós Graduação na Unopar
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- people aged from 18 to 60 years
- diagnosis of moderate to severe asthma, who underwent drug treatment for at least 6 months
- clinical stability for at least 1 month (without hospitalizations, emergency care use or medication changes)
- absence of cardiovascular and/or osteoneuromuscular diseases that could interfere/hinder the performance of tests and physical activity
- absence of lung diseases other than asthma
- preserved cognitive function
- non-smokers or ex-smokers with <10 pack-years
- report being physically inactive in accordance with current physical activity guidelines
- able to make video calls through any platform and/or free app available
Exclusion Criteria:
- presence of any new orthopedic limitation that hinders the performance of physical activity during the study
- perform ≥150 minutes per week of moderate to vigorous physical activity during the initial assessment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sham Comparator: Control group
This group will receive an education program which will cover information regarding asthma, physical activity and sedentary behavior.
|
The educational program will be delivered similarly to both groups through videos and booklets, which will be sent in all weekdays during de first week after the initial assessment.
Later, one educational material will be sent every two weeks until de 11th week.
In the first day, patients will receive a quick welcome video call, in which information will be provided on how this program will work.
In the subsequent days, the material will be sent daily and the participants will be able to ask questions, if they want to.
The program will cover information regarding the respiratory system, pathophysiology of asthma, asthma treatment, prevention strategies and medication instructions.
It will also be briefly addressed the subjects: understanding physical activity and sedentarism, as well as the importance and benefits of being physically active and less sedentary.
|
|
Experimental: Experimental group
In addition to the educational program, this group will receive weekly individual and/or group online sessions for 12 weeks of motivation-based on behavior change intervention to promote physical activity and reduce sedentary behavior, based on both self-determination theory and transtheoretical model.
They will also receive a pedometer with specific strategies related to it.
|
This is an online intervention based on the transtheoretical model, along with self-determination theory strategies.
This intervention will take place weekly summing up 12 online individual and/or group sessions of approximately 20 minutes.
The sessions will be made through a platform and/or application that makes video calls privately.
Each session will address a topic.
In addition, in all sessions, the patients gain during the previous week will be recognized, as well as new goals will be set for the next week.
The goals will always be individualized, realistic and achievable, based on the identification of each person's capacity and motivation.
A Fitbit Zip will be used to propose objective goals aimed at increasing physical activity and reduce sedentary behavior.
Additionally, a complex practice environment will be created around this device, such as the visualization of the number of steps evolution and competitions/games with other participants, among others.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time spent in physical activity
Time Frame: 12 weeks from randomization
|
Time spent (in minutes and percentage of the day) in light-intensity and moderate to vigorous physical activities, measured by a triaxial activity monitor.
|
12 weeks from randomization
|
|
Number of steps per day
Time Frame: 12 weeks from randomization
|
Number of steps per day measured by a triaxial activity monitor
|
12 weeks from randomization
|
|
Time spent in sedentary behavior
Time Frame: 12 weeks from randomization
|
Time spent (in minutes and percentage of the day) in sedentary activities, measured by a triaxial activity monitor.
|
12 weeks from randomization
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time spent in physical activity
Time Frame: 36 weeks from randomization
|
Time spent (in minutes and percentage of the day) in light-intensity and moderate to vigorous physical activities, measured by a triaxial activity monitor.
|
36 weeks from randomization
|
|
Number of steps per day
Time Frame: 36 weeks from randomization
|
Number of steps per day measured by a triaxial activity monitor.
|
36 weeks from randomization
|
|
Time spent in sedentary behavior
Time Frame: 36 weeks from randomization
|
Time spent (in minutes and percentage of the day) in sedentary activities, measured by a triaxial activity monitor.
|
36 weeks from randomization
|
|
Asthma control
Time Frame: 12 weeks from randomization
|
Asthma Control Questionnaire score ranging from 0 to 6; the lower, the better.
|
12 weeks from randomization
|
|
Asthma control
Time Frame: 36 weeks from randomization
|
Asthma Control Questionnaire score ranging from 0 to 6; the lower, the better.
|
36 weeks from randomization
|
|
Asthma symptoms and exacerbations
Time Frame: 12 weeks from randomization
|
Frequency of asthma symptoms and exacerbations
|
12 weeks from randomization
|
|
Asthma symptoms and exacerbations
Time Frame: 36 weeks from randomization
|
Frequency of asthma symptoms and exacerbations
|
36 weeks from randomization
|
|
Asthma medication use
Time Frame: 12 weeks from randomization
|
Frequency of asthma rescue medication use
|
12 weeks from randomization
|
|
Asthma medication use
Time Frame: 36 weeks from randomization
|
Frequency of asthma rescue medication use
|
36 weeks from randomization
|
|
Incremental Step Test
Time Frame: 12 weeks from randomization
|
Number of steps climbed; the more the better
|
12 weeks from randomization
|
|
Incremental Step Test
Time Frame: 36 weeks from randomization
|
Number of steps climbed; the more the better
|
36 weeks from randomization
|
|
Sit-To-Stand test
Time Frame: 12 weeks from randomization
|
Number of repetitions in 1 minute; the more the better
|
12 weeks from randomization
|
|
Sit-To-Stand test
Time Frame: 36 weeks from randomization
|
Number of repetitions in 1 minute; the more the better
|
36 weeks from randomization
|
|
Timed Up-and-Go test
Time Frame: 12 weeks from randomization
|
Time to perform the test; the faster the better
|
12 weeks from randomization
|
|
Timed Up-and-Go test
Time Frame: 36 weeks from randomization
|
Time to perform the test; the faster the better
|
36 weeks from randomization
|
|
4-Metre Gait Speed test
Time Frame: 12 weeks from randomization
|
Time to perform the test; the faster the better
|
12 weeks from randomization
|
|
4-Metre Gait Speed test
Time Frame: 36 weeks from randomization
|
Time to perform the test; the faster the better
|
36 weeks from randomization
|
|
Quality of life score
Time Frame: 12 weeks from randomization
|
Asthma Quality of Life Questionnaire; ranges from 1 to 7 points; the higher the score, the better the quality of life
|
12 weeks from randomization
|
|
Quality of life score
Time Frame: 36 weeks from randomization
|
Asthma Quality of Life Questionnaire; ranges from 1 to 7 points; the higher the score, the better the quality of life
|
36 weeks from randomization
|
|
Sleep quality
Time Frame: 12 weeks from randomization
|
Subjectively measured by Pittsburgh Sleep Quality Index (score ranges from 0 to 21; the lower, the better) and objectively measured by Actiwatch 2 (Philips Respironics, Murrysville, Pennsylvania, USA).
|
12 weeks from randomization
|
|
Sleep quality
Time Frame: 36 weeks from randomization
|
Subjectively measured by Pittsburgh Sleep Quality Index (score ranges from 0 to 21; the lower, the better) and objectively measured by Actiwatch 2 (Philips Respironics, Murrysville, Pennsylvania, USA).
|
36 weeks from randomization
|
|
Anxiety and depression symptoms
Time Frame: 12 weeks from randomization
|
Hospital Anxiety and Depression Scale; ranges from 0 to 21 points; the higher the score, the worse the anxiety and depression symptoms
|
12 weeks from randomization
|
|
Anxiety and depression symptoms
Time Frame: 36 weeks from randomization
|
Hospital Anxiety and Depression Scale; ranges from 0 to 21 points; the higher the score, the worse the anxiety and depression symptoms
|
36 weeks from randomization
|
|
Basic psychological needs
Time Frame: 12 weeks from randomization
|
Basic Psychological Needs in Exercise Scale; ranges from 4 to 20; higher scores indicate greater levels of satisfaction of basic psychological needs
|
12 weeks from randomization
|
|
Basic psychological needs
Time Frame: 36 weeks from randomization
|
Basic Psychological Needs in Exercise Scale; ranges from 4 to 20; higher scores indicate greater levels of satisfaction of basic psychological needs
|
36 weeks from randomization
|
|
Motivational regulations
Time Frame: 12 weeks from randomization
|
Behavioral Regulation in Exercise Questionnaire; ranges from 0 to 4; the higher the score, the more regulated the individual is for a given level
|
12 weeks from randomization
|
|
Motivational regulations
Time Frame: 36 weeks from randomization
|
Behavioral Regulation in Exercise Questionnaire; ranges from 0 to 4; the higher the score, the more regulated the individual is for a given level
|
36 weeks from randomization
|
|
Lung function
Time Frame: 12 weeks from randomization
|
Spirometry determining the forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and FEV1/FVC index.
|
12 weeks from randomization
|
|
Lung function
Time Frame: 36 weeks from randomization
|
Spirometry determining the forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and FEV1/FVC index.
|
36 weeks from randomization
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Joice Oliveira, Msc, Universidade Norte do Paraná
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OliveiraJM_PhD_FurlanettoKC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.